PECAM1 and clear cell adenocarcinoma: Also, in the axitinib-treated group, the number of vessels by CD31 was decreased in platinum sensitive high grade serous and clear cell carcinoma PDX, but this difference was not observed in platinum resistant high grade serous cases.